A study looking at using aspirin for pre cancerous white patches in the mouth (ASPOD)

Cancer type:

Head and neck cancers
Mouth (oral) cancer





This study looked at using aspirin to treat white patches in the mouth. This study was supported by Cancer Research UK.

White patches (leukoplakia) in the mouth are mostly harmless. But a small number may have changes in the cells (dysplasia) that if left untreated may develop into cancer. Doctors call these patches pre cancerous Open a glossary item.

Doctors can treat these pre cancerous patches with surgery. But sometimes they come back. So doctors are always looking for new ways to treat them, stop them coming back and stop them becoming cancer.

We knew from research that aspirin Open a glossary item may help protect some people from certain types of cancer. The researchers thought an aspirin mouthwash might help people with pre cancerous white patches in the mouth.

The aims of this study were to find out

  • How aspirin mouthwashes affected pre cancerous white patches in the mouth
  • How acceptable and safe it was for people to use aspirin mouthwashes
  • If it would be possible to do a trial with a larger number of people

Summary of results

The team found that doing the study in one hospital was difficult. This was mainly due to the small number of people who had pre cancerous white patches in their mouth.

This was a pilot (feasibility) study. The study team wanted to recruit 40 people. After 15 months they found only 15 people who were able to take part. Of these 15 people, 13 consented to take part. Only one person had pre cancerous white patches in their mouth.

At this stage the study’s management committee considered it was unlikely to recruit enough people into the study. So they decided to stop recruiting and closed the study.

The study team concluded that the question of using aspirin to treat pre cancerous patches in the mouth is an important question that remains unanswered. Future researchers would need to do a large multi centre trial Open a glossary item, possibly involving centres from other countries.   

We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (peer reviewed Open a glossary item) and published in a medical journal. The figures we quote above were provided by the trial team. We have not analysed the data ourselves.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Hisham Mehanna

Supported by

Cancer Research UK
NIHR Clinical Research Network: Cancer
University Hospitals Coventry and Warwickshire
Warwick Medical School Clinical Trials Unit

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 6692

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

Currently rated: 4 out of 5 based on 1 vote
Thank you!
We've recently made some changes to the site, tell us what you think